Kadimastem - Stem Cell to Cure Diseases
  • Robust Stem Cell
    Expansion Technologies

  • Diverse Stem Cell
    Differentiation Capabilities

  • Highly Sensitive Drug
    Screening Platform

  • Promising Therapeutic Programs

Stem Cell to Cure Diseases

Kadimastem (TASE:KDST) is a leading regenerative medicine company focused on the industrial development and commercialization of stem cell-based therapeutics, primarily for diabetes and neurodegenerative disorders.

The company’s proprietary technologies and know-how enable the differentiation of stem cells into insulin secreting beta cells as well as a range of neural cells (Oligodendrocytes, Astrocytes).  

Based on its platform technologies, Kadimastem is advancing two therapeutic programs in diabetes mellitus and ALS. 

News & Events